Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Volcanic Eruptions | 3 | 2019 | 3 | 1.220 |
Why?
|
| Respiratory Tract Diseases | 2 | 2018 | 31 | 1.030 |
Why?
|
| Air Pollutants | 2 | 2018 | 130 | 0.940 |
Why?
|
| Asthma | 7 | 2017 | 416 | 0.930 |
Why?
|
| Allergens | 3 | 2014 | 65 | 0.700 |
Why?
|
| Sulfuric Acids | 2 | 2019 | 4 | 0.650 |
Why?
|
| Sulfur Dioxide | 2 | 2019 | 9 | 0.640 |
Why?
|
| Smog | 1 | 2019 | 1 | 0.600 |
Why?
|
| Respiration Disorders | 1 | 2018 | 9 | 0.580 |
Why?
|
| Safety Management | 1 | 2018 | 17 | 0.570 |
Why?
|
| Hawaii | 11 | 2019 | 2011 | 0.550 |
Why?
|
| Respiratory Hypersensitivity | 2 | 2014 | 15 | 0.500 |
Why?
|
| Environmental Exposure | 1 | 2018 | 256 | 0.470 |
Why?
|
| Particulate Matter | 1 | 2016 | 83 | 0.460 |
Why?
|
| Hypertension | 1 | 2019 | 835 | 0.360 |
Why?
|
| Th2 Cells | 2 | 2007 | 62 | 0.290 |
Why?
|
| Caveolin 1 | 1 | 2007 | 33 | 0.270 |
Why?
|
| Prevalence | 3 | 2018 | 1612 | 0.270 |
Why?
|
| Air Pollution | 2 | 2019 | 87 | 0.250 |
Why?
|
| Transforming Growth Factor beta | 1 | 2007 | 216 | 0.240 |
Why?
|
| Down-Regulation | 1 | 2007 | 456 | 0.240 |
Why?
|
| Adolescent | 5 | 2021 | 6081 | 0.220 |
Why?
|
| Receptors, Interleukin-4 | 1 | 2003 | 10 | 0.210 |
Why?
|
| Young Adult | 4 | 2021 | 5080 | 0.210 |
Why?
|
| Hypersensitivity | 1 | 2003 | 32 | 0.200 |
Why?
|
| Humans | 15 | 2023 | 43102 | 0.200 |
Why?
|
| Students, Health Occupations | 1 | 2023 | 9 | 0.200 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 3156 | 0.190 |
Why?
|
| Immunoglobulin E | 3 | 2013 | 61 | 0.170 |
Why?
|
| Laboratories | 1 | 2021 | 40 | 0.170 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2003 | 863 | 0.150 |
Why?
|
| Schools | 2 | 2017 | 283 | 0.130 |
Why?
|
| Cardiac Myosins | 1 | 2016 | 7 | 0.130 |
Why?
|
| Rheumatic Fever | 1 | 2016 | 10 | 0.130 |
Why?
|
| Wind | 1 | 2016 | 12 | 0.120 |
Why?
|
| Smoking Cessation | 2 | 2018 | 590 | 0.120 |
Why?
|
| Male | 7 | 2018 | 23409 | 0.120 |
Why?
|
| Forced Expiratory Volume | 1 | 2016 | 75 | 0.120 |
Why?
|
| Schools, Medical | 1 | 2018 | 208 | 0.120 |
Why?
|
| Female | 7 | 2018 | 24698 | 0.120 |
Why?
|
| Aged | 3 | 2018 | 8214 | 0.120 |
Why?
|
| Autoantibodies | 1 | 2016 | 117 | 0.110 |
Why?
|
| Curriculum | 1 | 2018 | 318 | 0.110 |
Why?
|
| Risk Assessment | 1 | 2018 | 863 | 0.110 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 2853 | 0.110 |
Why?
|
| Environmental Monitoring | 1 | 2016 | 230 | 0.110 |
Why?
|
| Hepatitis B Antibodies | 1 | 2013 | 6 | 0.110 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2013 | 13 | 0.100 |
Why?
|
| Hepatitis B virus | 1 | 2013 | 18 | 0.100 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 167 | 0.100 |
Why?
|
| Disease Progression | 1 | 2016 | 667 | 0.100 |
Why?
|
| Risk Factors | 2 | 2018 | 3994 | 0.100 |
Why?
|
| Middle Aged | 3 | 2018 | 12222 | 0.100 |
Why?
|
| Heart Failure | 1 | 2016 | 302 | 0.090 |
Why?
|
| Students | 1 | 2017 | 626 | 0.090 |
Why?
|
| Healthcare Disparities | 1 | 2016 | 590 | 0.080 |
Why?
|
| Child | 2 | 2016 | 3443 | 0.080 |
Why?
|
| Smoking | 1 | 2017 | 1024 | 0.080 |
Why?
|
| Adult | 2 | 2018 | 13872 | 0.080 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2007 | 6 | 0.070 |
Why?
|
| Interleukins | 1 | 2007 | 40 | 0.070 |
Why?
|
| Lymphocyte Subsets | 1 | 2007 | 21 | 0.070 |
Why?
|
| Pulmonary Fibrosis | 1 | 2007 | 38 | 0.070 |
Why?
|
| Selenoprotein P | 1 | 2007 | 45 | 0.060 |
Why?
|
| Flow Cytometry | 1 | 2007 | 411 | 0.060 |
Why?
|
| Selenium | 1 | 2007 | 155 | 0.060 |
Why?
|
| Education, Medical, Continuing | 1 | 2005 | 35 | 0.060 |
Why?
|
| General Surgery | 1 | 2005 | 28 | 0.060 |
Why?
|
| Physician's Role | 1 | 2005 | 40 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2007 | 1035 | 0.050 |
Why?
|
| Lung | 1 | 2007 | 492 | 0.050 |
Why?
|
| Eosinophils | 1 | 2003 | 24 | 0.050 |
Why?
|
| Counseling | 1 | 2005 | 138 | 0.050 |
Why?
|
| Family Health | 1 | 2003 | 55 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2003 | 93 | 0.050 |
Why?
|
| Problem Solving | 1 | 2023 | 38 | 0.050 |
Why?
|
| Gene Frequency | 1 | 2003 | 206 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2005 | 146 | 0.050 |
Why?
|
| Time Factors | 1 | 2007 | 1857 | 0.050 |
Why?
|
| Interprofessional Relations | 1 | 2023 | 59 | 0.050 |
Why?
|
| Mice | 3 | 2007 | 6644 | 0.050 |
Why?
|
| Learning | 1 | 2023 | 161 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2023 | 231 | 0.040 |
Why?
|
| Genotype | 1 | 2003 | 800 | 0.040 |
Why?
|
| Universities | 1 | 2023 | 559 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2007 | 2157 | 0.040 |
Why?
|
| Ovalbumin | 2 | 2007 | 47 | 0.030 |
Why?
|
| Streptococcus pyogenes | 1 | 2016 | 29 | 0.030 |
Why?
|
| Education, Medical | 1 | 2018 | 118 | 0.030 |
Why?
|
| Animals | 3 | 2007 | 16992 | 0.030 |
Why?
|
| Epitopes | 1 | 2016 | 157 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 458 | 0.030 |
Why?
|
| Adolescent Behavior | 1 | 2017 | 281 | 0.030 |
Why?
|
| Hepatitis B Vaccines | 1 | 2013 | 12 | 0.030 |
Why?
|
| Seroepidemiologic Studies | 1 | 2013 | 74 | 0.030 |
Why?
|
| Comorbidity | 1 | 2016 | 737 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2007 | 1271 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 259 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2016 | 1759 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2013 | 1546 | 0.020 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2007 | 18 | 0.020 |
Why?
|
| STAT6 Transcription Factor | 1 | 2007 | 17 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2007 | 55 | 0.020 |
Why?
|
| Glutathione Peroxidase | 1 | 2007 | 112 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 652 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2007 | 694 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2007 | 279 | 0.010 |
Why?
|
| Role Playing | 1 | 2005 | 3 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2007 | 986 | 0.010 |
Why?
|
| Cytokines | 1 | 2007 | 678 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 1869 | 0.010 |
Why?
|
| Inflammation | 1 | 2007 | 758 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 2002 | 148 | 0.010 |
Why?
|
| Diet | 1 | 2007 | 826 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2002 | 140 | 0.010 |
Why?
|
| Community Health Services | 1 | 2002 | 206 | 0.010 |
Why?
|
| Telemedicine | 1 | 2002 | 234 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2002 | 1604 | 0.010 |
Why?
|